{
  "model": "claude-sonnet-4-20250514",
  "prompt_version": "v1",
  "prompt_name": "Basic sentence generation",
  "timestamp": "2026-01-19T20:50:47.596974",
  "per_article_results": [
    {
      "pmcid": "PMC5508045",
      "variants": [
        {
          "variant": "rs9923231",
          "generated": "rs9923231 is associated with decreased warfarin dose requirements when treated with warfarin in Thai patients as compared to wild-type genotype.",
          "ground_truth": [
            "Genotypes CT + TT are associated with decreased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism or Venous Thrombosis as compared to genotype CC."
          ],
          "best_similarity": 0.2702702702702703,
          "best_match_idx": 0,
          "best_match": "Genotypes CT + TT are associated with decreased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism or Venous Thrombosis as compared to genotype CC.",
          "all_similarities": [
            0.2702702702702703
          ]
        },
        {
          "variant": "rs1057910",
          "generated": "CYP2C9*3 variant allele (rs1057910) is associated with significantly lower warfarin stable weekly doses when treated with warfarin in Thai patients as compared to homozygous wild-type.",
          "ground_truth": [
            "Genotypes AC + CC are associated with decreased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to genotype AA."
          ],
          "best_similarity": 0.15555555555555556,
          "best_match_idx": 0,
          "best_match": "Genotypes AC + CC are associated with decreased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to genotype AA.",
          "all_similarities": [
            0.15555555555555556
          ]
        },
        {
          "variant": "rs2108622",
          "generated": "Genotype TT of CYP4F2 rs2108622 is associated with increased warfarin dose requirements when treated with warfarin in Thai patients as compared to genotype CC.",
          "ground_truth": [
            "Genotype TT is associated with increased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to genotype CC."
          ],
          "best_similarity": 0.42424242424242425,
          "best_match_idx": 0,
          "best_match": "Genotype TT is associated with increased dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to genotype CC.",
          "all_similarities": [
            0.42424242424242425
          ]
        },
        {
          "variant": "rs887829",
          "generated": "UGT1A1 rs887829 is not associated with stable weekly warfarin dose requirements when treated with warfarin in Thai patients as compared to wild-type allele carriers.",
          "ground_truth": [
            "Allele C is not associated with dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to allele T."
          ],
          "best_similarity": 0.2972972972972973,
          "best_match_idx": 0,
          "best_match": "Allele C is not associated with dose of warfarin in people with Atrial Fibrillation, heart valve replacement, Hypertension, Pulmonary, Pulmonary Embolism and Venous Thrombosis as compared to allele T.",
          "all_similarities": [
            0.2972972972972973
          ]
        }
      ],
      "avg_similarity": 0.2868413868413868
    },
    {
      "pmcid": "PMC554812",
      "variants": [
        {
          "variant": "HLA-B*58:01",
          "generated": "HLA-B*58:01 is associated with severe cutaneous adverse reactions when treated with allopurinol in Han Chinese as compared to allopurinol-tolerant patients and healthy subjects.",
          "ground_truth": [
            "HLA-B *58:01 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol."
          ],
          "best_similarity": 0.37037037037037035,
          "best_match_idx": 0,
          "best_match": "HLA-B *58:01 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol.",
          "all_similarities": [
            0.37037037037037035
          ]
        },
        {
          "variant": "HLA-DRB1*03:01",
          "generated": "HLA-DRB1*03:01 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol in Han Chinese as compared to allopurinol-tolerant patients and healthy controls.",
          "ground_truth": [
            "HLA-DRB1 *03:01 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol."
          ],
          "best_similarity": 0.48148148148148145,
          "best_match_idx": 0,
          "best_match": "HLA-DRB1 *03:01 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol.",
          "all_similarities": [
            0.48148148148148145
          ]
        },
        {
          "variant": "HLA-C*03:02",
          "generated": "HLA-C*03:02 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol in Han Chinese as compared to allopurinol-tolerant patients and general population controls.",
          "ground_truth": [
            "HLA-C *03:02 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol."
          ],
          "best_similarity": 0.4642857142857143,
          "best_match_idx": 0,
          "best_match": "HLA-C *03:02 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol.",
          "all_similarities": [
            0.4642857142857143
          ]
        },
        {
          "variant": "HLA-A*33:03",
          "generated": "HLA-A*33:03 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol in Han Chinese as compared to allopurinol-tolerant patients and healthy subjects.",
          "ground_truth": [
            "HLA-A *33:03 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol."
          ],
          "best_similarity": 0.48148148148148145,
          "best_match_idx": 0,
          "best_match": "HLA-A *33:03 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol.",
          "all_similarities": [
            0.48148148148148145
          ]
        },
        {
          "variant": "rs1594",
          "generated": "Based on the article text, I cannot generate a sentence describing the pharmacogenetic association for rs1594 because this variant is not the main focus of the study and insufficient information is provided about its specific association.\n\nThe article mentions rs1594 only briefly as one of two SNPs in the CFLAR gene that showed potential association (P < 0.01) in the initial screen, but no specific effect size, population details, or clinical outcome data are provided for this variant. The study's primary focus is on HLA-B*5801 and its strong association with allopurinol-induced severe cutaneous adverse reactions.",
          "ground_truth": [
            "Allele A is associated with severe cutaneous adverse reactions when treated with allopurinol as compared to allele G."
          ],
          "best_similarity": 0.1038961038961039,
          "best_match_idx": 0,
          "best_match": "Allele A is associated with severe cutaneous adverse reactions when treated with allopurinol as compared to allele G.",
          "all_similarities": [
            0.1038961038961039
          ]
        }
      ],
      "avg_similarity": 0.38030303030303025
    }
  ],
  "avg_similarity": 0.33876452209785546,
  "total_variants": 9
}